Corrigendum to "Diosgenin alleviates hypercholesterolemia via SRB1/CES-1/CYP7A1/FXR pathway in high-fat diet-fed rats" Toxicology and Applied Pharmacology, volume 412C (2021)

Toxicol Appl Pharmacol. 2021 Mar 1:414:115423. doi: 10.1016/j.taap.2021.115423. Epub 2021 Jan 26.

Authors

Lu Yu¹, Haifei Lu¹, Xiufen Yang¹, Ruoqi Li², Jingjing Shi¹, Yantong Yu¹, Chaoqun Ma¹, Fengcui Sun¹, Shizhao Zhang¹, Fengxia Zhang³

Affiliations

¹ Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.
² Zhejiang Chinese Medical University, Hangzhou 310058, China.
³ Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China. Electronic address: fxzhang0987@163.com.

PMID: 33508267
DOI: 10.1016/j.taap.2021.115423

No abstract available

Publication types

Published Erratum